SEC Form 3 · accession 0001179110-17-010516
Kala Pharmaceuticals, Inc. · KALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin Hanes
10% Owner
Period of report
Jul 19, 2017
Accepted (ET)
Jul 19, 2017 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001479419
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 601,923 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney